Benefit-Cost Analysis of Rubella Vaccination Policy
Open accessThe DOI matches its Crossref record.
Abstract
To analyze rubella vaccination strategies we calculated benefits and costs of prevention or rubella. With no vaccination, lifetime expenditures for congenital rubella syndrome in offspring of females are greater than $35 per female (present value). Expenditures for acute rubella are less than $2.70 per person. Cost, when monovalent vaccine is used, is $3.00 per person. Vaccination of females at 12 years of age yields net benefits 80 per cent larger than vaccination of children at two. When only 80 per cent of the target group accepts vaccine, vaccination at 12 years reduces congenital rubella by 30 per cent more than vaccination at six or two. Vaccination at two and revaccination at 12 (with 80 per cent acceptance at each age) reduces expected natural infections by 80 per cent and expected congenital rubella by 95 per cent. Either single vaccination of females at 12 years or vaccination at two ages would be better than current United States practice of vaccinating children once at an early age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Clinical Economics: A Guide to the Economic Analysis of Clinical Practices
Eisenberg, J. M. (1989) · JAMA · doi:10.1001/jama.1989.03430200123038 · Cited by 690
Towards a new approach for estimating indirect costs of disease
Koopmanschap, M. A., & van Ineveld, B. M. (1992) · Social Science & Medicine · doi:10.1016/0277-9536(92)90131-9 · Cited by 319
O'Brien, B., & Gafni, A. (1996) · Medical Decision Making · doi:10.1177/0272989x9601600314 · Cited by 294
Benefits, risks and costs of immunization for measles, mumps and rubella.
White, C. C., Koplan, J. P., & Orenstein, W. A. (1985) · American Journal of Public Health · doi:10.2105/ajph.75.7.739 · Cited by 193
Neurologic disorders after measles-mumps-rubella vaccination
Mäkelä, A., Nuorti, J. P., & Peltola, H. (2002) · PEDIATRICS · doi:10.1542/peds.110.5.957 · Cited by 183
Metadata
- Authors
- Schoenbaum, S. C., Hyde, J. N., Bartoshesky, L., & Crampton, K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1976-02-05
- Volume
- 294
- Issue
- 6
- Pages
- 306-310
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1988952112
- Cited by
- 110
- References
- 0
- FWCI
- 33.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benefit-Cost Analysis of Rubella Vaccination Policy. https://app.cochat.ai/papers/10.1056/nejm197602052940604
- The paper
- Schoenbaum, S. C., Hyde, J. N., Bartoshesky, L., & Crampton, K. (1976). Benefit-Cost Analysis of Rubella Vaccination Policy. New England Journal of Medicine. https://doi.org/10.1056/nejm197602052940604
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.